Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda B Spurdle

Showing results (181-190 of 398) with videos related to

Pageof 40
Sort By:
European Journal of Human Genetics : EJHG|May 25, 2024
Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics servicesStephanie Best, Zoe Fehlberg, Christopher Richards, et al.
International Journal of Cancer|December 10, 2002
BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer riskAnnika Auranen, Amanda B Spurdle, Xiaoqing Chen, et al.
Frontiers in Genetics|December 6, 2019
Comprehensive Assessment of <i>BARD1</i> Messenger Ribonucleic Acid Splicing With Implications for Variant ClassificationLogan C Walker, Vanessa Lilian Lattimore, Anders Kvist, et al.
Journal of Medical Genetics|April 24, 2010
A BRCA1 promoter variant (rs11655505) and breast cancer riskPaolo Verderio, Sara Pizzamiglio, Melissa C Southey, et al.
American Journal of Human Genetics|June 6, 2025
Consultation informs strategies for improving the use of functional evidence in variant classificationRehan M Villani, Bronwyn Terrill, Emma Tudini, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Consultation informs strategies to improve functional evidence use in variant classificationRehan M Villani, Bronwyn Terrill, Emma Tudini, et al.
JCO Precision Oncology|September 2, 2025
Case-Control Study for 23 Cancer Types With Functional Analysis of <i>CHEK2</i>: Risk Estimation and Clinical Recommendations in East AsiaYuri Takehara, Yoshiaki Usui, Lenka Stolařová, et al.
Human Mutation|September 16, 2016
Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene VariantsRossella Tricarico, Mariann Kasela, Cristina Mareni, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
APPLICATION OF THE ACMG/AMP FRAMEWORK TO CAPTURE EVIDENCE RELEVANT TO PREDICTED AND OBSERVED IMPACT ON SPLICING: RECOMMENDATIONS FROM THE CLINGEN SVI SPLICING SUBGROUPLogan C Walker, Miguel de la Hoya, George A R Wiggins, et al.
Journal of the National Cancer Institute|April 3, 2024
TP53-associated early breast cancer: new observations from a large cohortRenata L Sandoval, Michele Bottosso, Li Tianyu, et al.
Pageof 40

Showing results (181-190 of 398) with videos related to

Sort By:
Pageof 40
European Journal of Human Genetics : EJHG|May 25, 2024
Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics servicesStephanie Best, Zoe Fehlberg, Christopher Richards, et al.
International Journal of Cancer|December 10, 2002
BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer riskAnnika Auranen, Amanda B Spurdle, Xiaoqing Chen, et al.
Frontiers in Genetics|December 6, 2019
Comprehensive Assessment of <i>BARD1</i> Messenger Ribonucleic Acid Splicing With Implications for Variant ClassificationLogan C Walker, Vanessa Lilian Lattimore, Anders Kvist, et al.
Journal of Medical Genetics|April 24, 2010
A BRCA1 promoter variant (rs11655505) and breast cancer riskPaolo Verderio, Sara Pizzamiglio, Melissa C Southey, et al.
American Journal of Human Genetics|June 6, 2025
Consultation informs strategies for improving the use of functional evidence in variant classificationRehan M Villani, Bronwyn Terrill, Emma Tudini, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
Consultation informs strategies to improve functional evidence use in variant classificationRehan M Villani, Bronwyn Terrill, Emma Tudini, et al.
JCO Precision Oncology|September 2, 2025
Case-Control Study for 23 Cancer Types With Functional Analysis of <i>CHEK2</i>: Risk Estimation and Clinical Recommendations in East AsiaYuri Takehara, Yoshiaki Usui, Lenka Stolařová, et al.
Human Mutation|September 16, 2016
Assessment of the InSiGHT Interpretation Criteria for the Clinical Classification of 24 MLH1 and MSH2 Gene VariantsRossella Tricarico, Mariann Kasela, Cristina Mareni, et al.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2023
APPLICATION OF THE ACMG/AMP FRAMEWORK TO CAPTURE EVIDENCE RELEVANT TO PREDICTED AND OBSERVED IMPACT ON SPLICING: RECOMMENDATIONS FROM THE CLINGEN SVI SPLICING SUBGROUPLogan C Walker, Miguel de la Hoya, George A R Wiggins, et al.
Journal of the National Cancer Institute|April 3, 2024
TP53-associated early breast cancer: new observations from a large cohortRenata L Sandoval, Michele Bottosso, Li Tianyu, et al.
Pageof 40